Showing 1,941–1,960 of 17,937 drug recalls
Drug Recall
Ongoing
Historical record Class II
Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54 by Legacy Pharmaceutical Packaging LLC
Reason
CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product. Recall initiated
December 11, 2023 Reported by FDA
January 3, 2024 Distribution
CA and AR
View recall →
Drug Recall
Terminated
Historical record Class II
Thiamine HCl/Pyridoxine HCl 20 mg/mL /100mg/ml Injection Solution, 30mL Amber Glass Vial, Rx only, AnazaoHealth, 7465 W. Sunset Road, Las Vegas, NV, NDC 72682-8721-3. by AnazaoHealth Corporation
Reason
Presence of Particulate Matter. Recall initiated
November 22, 2023 Reported by FDA
January 3, 2024 Distribution
Nationwide in the USA.
View recall →
Drug Recall
Terminated
Historical record Class II
B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3 by AnazaoHealth Corporation
Reason
Presence of Particulate Matter. Recall initiated
November 22, 2023 Reported by FDA
January 3, 2024 Distribution
Nationwide in the USA.
View recall →
Drug Recall
Terminated
Historical record Class II
Inhub Wixela (fluticasone propionate and salmeterol inhalation powder, USP) 500/50MCG, 60 Doses of Inhalation Powder, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-9320-32 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Warfarin Sodium Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 0093-1721-01 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Warfarin Sodium Tablets, USP, 2.5 mg, 100 Tablets per bottle, Rx only, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 0093-1714-01 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Triamterene and Hydrochlorothiazide Capsules, USP, 37.5 mg/25 mg, 100 capsules per bottle, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19136. NDC 0527-1632-01 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Terconazole Vaginal Suppositories, 80 mg, 3 Suppositories with Vaginal Applicator, Rx only, Manufactured by: Cosette Pharmaceuticals, Inc., 111 Coolidge Street, South Plainfield, NJ 07080. NDC: 0713-0552-73 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
SPIRIVA HANDIHALER (tiotropium bromide inhalation powder) 18 mcg/Capsule, 30 capsules, 3 blister cards, each card contains 10 capsules, Rx only, For oral inhalation only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. NDC: 0597-0075-41 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
RIVASTIGMINE TRANSDERMAL SYSTEM, Delivers 4.6 mg/24 hours, 30 systems per box, Rx Only, Distributed by: Alvogen, Inc., Morristown, NJ 07960. NDC 47781-304-03 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Ricola CherryHoney Herb Throat Drops (menthol, 1.8 mg), 10 Drops per roll, Manufacturer: Ricola Ltd., 4242 Laufen, Switzerland; Distributed by: Ricola USA Inc., 6 Campus Drive, 2nd Floor South, Parsippany, NJ 07054. NDC: 54305-507-10 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Propranolol Hydrochloride Tablets, 20 mg, 100 Tablets per bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC: 69238-2078-1 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
PredniSONE Tablets, USP, 20 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801. NDC: 59746-175-06 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Nyamyc, 100,000 USP units per gram, 60 grams, Rx only, Topical Use Only, Manufactured by: Upsher-Smith Laboratories, Inc, Minneapolis, MN 55447. by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454. NDC: 45963-676-96 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Meloxicam Tablets, USP, 15 mg, 1000 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., Kurkumbh, India; Manufactured for: Cipla USA, Inc., 9100 S. Dadeland Blvd., Suite 1500 Miami, FL 33156. NDC: 69097-159-15 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-1300-01 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Lisinopril and Hydrochlorothiazide Tablets USP, 10mg/12.5mg, Rx only, 100 Tablets per bottles, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Nagpur-441 108, India. NDC: 68180-518-01 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Lillow (Levonorgestrel and Ethinyl Estradiol Tablets, USP), 0.15 mg/0.03 mg, 1 Blister Pack Containing 28 Tablets, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC 69238-1554-6 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Leader Nasal Decongestant PE (Phenylephrine HCl 10 mg), 18 Tablets per cartons, Distributed By Cardinal Health, Dublin, Ohio 43017. NDC: 70000-0126-1 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Data last updated: September 9, 2026 ET
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer .
